Viewing Study NCT02320305

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:08 AM
Ignite Modification Date: 2026-02-28 @ 10:44 AM
Study NCT ID: NCT02320305
Status: COMPLETED
Last Update Posted: 2020-01-14
First Post: 2014-12-15
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery
Sponsor: Mayo Clinic
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stage IIA Skin Melanoma View
None Stage IIB Skin Melanoma View
None Stage IIC Skin Melanoma View
None Stage IIIA Skin Melanoma View
None Stage IIIB Skin Melanoma View
None Stage IIIC Skin Melanoma View
None Stage IV Skin Melanoma View
Keywords: